How can MRD and disease be assessed in routine practice?
T-Cell engaging treatment in AML
Effective antibody therapy and updates from the POLLUX and CASTER trials at IMW
Developing targeted therapies to combine with venetoclax in acute myeloid leukemia (AML)
The structure IC-APL and how it is helping APL patients in developing countries